Individualized thyrotropin suppression in patients with differentiated thyroid cancers
10.3760/cma.j.issn.1000-6699.2011.06.001
- VernacularTitle:分化型甲状腺癌患者需要个体化的TSH抑制
- Author:
Yao BAI
;
Xiaolan LIAN
- Publication Type:Journal Article
- Keywords:
Differentiated thyroid cancers;
Thyrotropin suppressive therapy;
Thyrotropin;
Individualization
- From:
Chinese Journal of Endocrinology and Metabolism
2011;27(6):451-453
- CountryChina
- Language:Chinese
-
Abstract:
The epidemic characteristics of differentiated thyroid cancer(DTC)are changing, thyrotropin(TSH)suppressive therapy is also improving in recent years. The risks of recurrence and the death of patients, as well as the adverse effects of levothyroxine sodium treatment should be fully considered during thyroid hormone administration for patients of DTC. Hence, the degree of TSH suppression should be individualized in patients with DTC.
